A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis.

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42632293

Chikara Ohyama; Hayato Yamamoto; Masanao Shinohara; Naoki Fujita; Shingo Hatakeyama; Takaki Ichiyama; Takuma Narita; Teppei Okamoto; Tomoko Hamaya

Aug 23, 2026